Search - tctmd.com

Displaying 121 - 140 of 166

Sort: Relevancy | Date

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

CV Screening, Care at UK Football Club Made Inroads Against HF

Caitlin E. Cox

March 07, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

Genetic Risk Score for Endothelial Cell Dysfunction Identifies Patients at Risk

News Daily News

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

Michael O'Riordan

February 27, 2025

News Daily News

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Yael L. Maxwell

February 25, 2025

News Daily News

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

Todd Neale

February 25, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

Presentation THT 2025

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Presenter: Dor Lotan

February 12, 2025

News Conference News ISC 2025

GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke

Caitlin E. Cox

February 11, 2025

Presentation THT 2025

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Presenter: Sanjiv Shah

February 11, 2025

News Conference News ISC 2025

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

Todd Neale

February 11, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

Presentation THT 2025

Salt and HF: Addressing the Controversies of Molecular Mechanisms, Physiology, Clinical Data

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2025

Harnessing Real World Data to Test Emerging Technologies

Presenter: Robert Yeh

February 11, 2025

Presentation THT 2025

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Presenter: Jeffrey Testani

February 11, 2025

Advertisement

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

CV Screening, Care at UK Football Club Made Inroads Against HF

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Survey Calls Out Implicit Bias in Peripheral Vascular Care

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Positive Results With Carillon Mitral Device Seen in Real-world Registries

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

Salt and HF: Addressing the Controversies of Molecular Mechanisms, Physiology, Clinical Data

Harnessing Real World Data to Test Emerging Technologies

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content